Bayer loses Roundup appeal as US Supreme Court backs $25m damages award

German pharmaceutical firm Bayer has lost its appeal to dismiss Roundup cancer claims before the US Supreme Court, which upheld a $25m award to Edwin Hardeman who claimed the weedkiller caused his cancer.

Bayer filed the appeal in August last year as part of its plan to limit mounting liability c...


Want to read this article?

Register for ultimate access to this article and ALL our premium content

ULTIMATE ACCESS PROVIDES YOU WITH

  • Unrestricted access to Commercial Risk, Commercial Risk Europe and Global Risk Manager news, exclusive expert analysis and opinion
  • Breaking news, daily and/or weekly Commercial Risk Europe newsletters and regular digital publications
  • Breaking news, weekly and monthly Global Risk Manager newsletters and quarterly digital Journal
  • European and global surveys, rankings and special reports
  • National European local language newsletters
  • Preferential access to webinars and virtual and physical conferences

If you are already a registered user or subscriber you can LOGIN below for ultimate access:

Back to top button